NCT06067503 2026-04-13
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Phase 2 Recruiting
Clinical Trials
11 trialsNCT07418125 2026-02-18
GALIA
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT06068075 2026-01-22
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT07358715 2026-01-22
Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
National University Hospital, Singapore
Phase NA Recruiting
NCT05384769 2025-10-07
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
City of Hope Medical Center
Phase NA Recruiting
NCT04258137 2025-10-02
COPE
Institut Bergonié
Phase NA Recruiting
NCT06989814 2025-08-11
SMART
Erasmus Medical Center
Phase NA Recruiting
NCT05810402 2025-07-10
LILIPSY
University Hospital, Montpellier
Phase NA Recruiting
NCT05283044 2025-06-25
PRISM-POrTAL
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Recruiting
NCT05298722 2025-04-02
PeRFormanCe
University Hospital, Ghent
Phase NA Recruiting
NCT06268405 2024-10-01
Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings
University Health Network, Toronto
Phase NA Recruiting